182
T
Tail regeneration , 60–64
Tissue engineering , 68
Tissue repair ability , 67
Tissue vascularity , 94
TNFα. See Tumor necrosis factor α (TNFα)
Trabecular bone pattern , 82
Transcriptomes , 60
Transforming growth factor-β (TGFβ) , 59 , 63 , 72
Transgenic BMP , 91
Transient cartilaginous callus , 86
Transwell migration assays , 89
Tumor necrosis factor α (TNFα) , 126 , 127
Turbulent microenvironment , 94
U
Unamputated mouse digit , 81
Urodeles , 60 , 61 , 63–65 , 79 , 80 , 89
V
Vascular endothelial growth factor (VEGF) ,
59 , 60
administration , 151
anti-infl ammatory effects , 128
anti-infl ammatory properties , 133
glutamate-induced excitotoxicity , 128
hypoxia/hypoglycemia , 129
lipopolysaccharide stimulated (LPS) , 128
neuroprotective effects , 133
NPSCs , 133 , 134
post-ischemia/reperfusion injury , 128
stroke , 132
Vascular endothelial growth factor A (VegfA) ,
9 2 , 9 3
Vascularized marrow cavity , 80
Vasculature , 81 , 94
VEGF. See Vascular endothelial growth factor
(VEGF)
VEGF-soaked beads , 92
Vertebrate cartilage regeneration , 61W
WNT signaling , 91
Wound closure , 81
Wound epidermis (WE) , 81 , 87 , 90
Wound healing , 1 , 6 , 8 , 9 , 11
Wound to blastema , 92 , 94–97X
Xenopus frogs , 60
Xenopus tadpole , 8 3Z
Zebrafi sh fi n regeneration , 89Index